Funded Tech Companies
Molecular Partners
Looking for the VC firms that provided funding to Molecular Partners? Johnson & Johnson Development Corporation, Index Ventures and EW Healthcare Partners joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Molecular Partners
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Wagistrasse 14
Zürich-Schlieren, 8952
Switzerland
Zürich-Schlieren, 8952
Switzerland
Phone
Website
Email Address
Company Background Information
Overview
Molecular Partners is a privately held biotech company focusing on the commercialization of a novel class of biological drugs known as DARPins. The company is using/exploiting this novel class of protein therapeutics to create medicines for diseases with unmet medical need and to dramatically improve existing therapies.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/15/2009
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Amstutz
Chief Financial Officer
Andreas Emmenegger
Chief Operating Officer
Michael Stumpp
VP - Finance
Robert Hendriks
VP - General Counsel
Julien Gander
VP - Human Resources
Thomas Schwerzmann
Company Investors
- Johnson & Johnson Development Corporation
- Index Ventures (Francesco Rubertis)
- EW Healthcare Partners (Petri Vainio)
- BB Biotech Ventures
Browse more funded tech companies:
Molecular Medicine BioServices | Molecular Sensing
Share this article
About Our VC & M&A Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs